NovoCure NVCR
NASDAQ NVCR
$15.75 +0.04 (+0.25%)
As of: Oct 21, 2026 · 12:54 PM EDT

NovoCure (NVCR) Notes Payables (2024 - 2025)

Updated

NovoCure's Notes Payables was $560.62 million in Q3 2025, up 0.6% from $557.33 million a year earlier and up 0.1% from the prior quarter.

Analysis

NovoCure (NVCR) Notes Payables (2024 - 2025) Analysis & Trends

At the end of FY2024, Notes Payables at NovoCure came in at $558.16 million.

  • Per Business Quant data, NVCR's Notes Payables in the three quarters before Q3 2025 was $559.79 million (Q2 2025), $558.97 million (Q1 2025) and $558.16 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.70 Bn 237.73 Bn 4.88 Bn
2 Abbott Laboratories 171.57 Bn 142.00 Bn 7.27 Bn
3 Danaher 162.29 Bn 146.10 Bn 3.61 Bn
4 Intuitive Surgical 150.18 Bn 129.60 Bn 1.96 Bn
5 Medtronic 119.47 Bn 84.72 Bn 6.34 Bn
6 Stryker 113.91 Bn 100.03 Bn 4.50 Bn
7 Boston Scientific 65.30 Bn 60.07 Bn 3.85 Bn
8 Becton Dickinson 53.51 Bn 50.66 Bn 2.32 Bn
9 Edwards Lifesciences 50.73 Bn 34.74 Bn 1.35 Bn
10 NovoCure 1.83 Bn -528.28 Mn 142.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 560.62 Mn
Jun 30, 2025 559.79 Mn
Mar 31, 2025 558.97 Mn
Dec 31, 2024 558.16 Mn
Sep 30, 2024 557.33 Mn
API Access

NovoCure Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=NVCR&period=max&api_key=YOUR_API_KEY